M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine for tuberculosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Oct 2023: Trial registered, NCT06062238
  2. 5 Mar 2024: Trial started, NCT06062238

The trials

NCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

State
Under way
Phase
Phase 3
People
20,080 taking part
Started
5 Mar 2024
Primary completion
Apr 2028
Arms
Participants receiving M72/AS01E-4
Results
None posted
  1. 2 Oct 2023: Trial registered
  2. 5 Mar 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.